MYCOPLASMA PNEUMONIAE PNEUMONIA IN CHILDREN – CASE REPORT

Authors

  • Andreja Prijić Clinical Hospital Center “Dr Dragiša Mišović - Dedinje”, Children’s Hospital for Lung Diseases and Tuberculosis, Belgrade, Serbia
  • Olivera Ostojić Special Hospital "Sokobanja", Sokobanja, Serbia
  • Jasmina Jocić Stojanović Clinical Hospital Center “Dr Dragiša Mišović - Dedinje”, Children’s Hospital for Lung Diseases and Tuberculosis, Belgrade, Serbia
  • Milka Micić Stanojević Special Hospital "Sokobanja", Sokobanja, Serbia
  • Vesna žVeković Special Hospital "Sokobanja", Sokobanja, Serbia
  • Sergej Prijić Institute for Mother and Child Health Care of Serbia, Belgrade, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Zorica Živković Clinical Hospital Center “Dr Dragiša Mišović - Dedinje”, Children’s Hospital for Lung Diseases and Tuberculosis, Belgrade, University Business Academy in Novi Sad, Faculty of Pharmacy, Novi Sad, Serbia

DOI:

https://doi.org/10.46793/PP151024013P

Keywords:

Mycoplasma pneumonia, pneumonia, macrolide antibiotics

Abstract

Introduction. Mycoplasma pneumoniae causes atypical pneumonia in paediatric patients.

Case report.In our paper we present a 9.5 years old patient with pneumonia caused by Mycoplasma pneumoniae. Unsatisfactory response to macrolide antibiotic treatment and complicated clinical course were demonstrated. Antimicrobial therapy revision was introduced regarding clinical suspicion on the combined etiology aiming for appropriate prevention of additional complications. Subsequently, disease regression and clinical status normalization were registered.

Conclusion.Infections caused by mycoplasma pneumonia in paediatric population are usually associated with mild clinical course. However, this microorganism non-rarely causes atypical pneumonia. In patients with complicated lung infection, deteriorated clinical course and poor treatment response, both diagnostic reevaluation and treatment approach revisions are required.

References

Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008 Nov;32(6):956-73.

Lee KY. Paediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther. 2008 Aug;6(4):509-21.

Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest. 2007 Dec;132(6):1962-6.

Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2012 Feb;55(2):42-7.

Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Paediatrics. 2004 Apr;113(4):701-7.

Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995 Jun;14(6):471-7.

Gendrel D, Raymond J, Moulin F, Iniguez JL, Ravilly S, Habib F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis. 1997 May;16(5):388-91.

Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J. 1998 Oct;17(10):865-71.

Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 1998 Nov;17(11):986-91.

Principi N, Esposito S, Blasi F, Allegra L. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis. 2001 May 1;32(9):1281-9.

Tsolia MN, Psarras S, Bossios A, Audi H, Paldanius M, Gourgiotis D, et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004 Sep 1;39(5):681-6.

Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, et al. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr. 2010;10:48.

Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011 Oct;66 Suppl 2:ii1-23.

Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in paediatric patients. J Infect Chemother. 2009 Dec;15(6):380-3.

Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006 Feb;50(2):709-12.

Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis. 2011 Jun;17(6):1079-82.

Miyashita N, Maruyama T, Kobayashi T, Kobayashi H, Taguchi O, Kawai Y, et al. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. J Infect Chemother. 2011 Feb;17(1):114-8.

Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2006 Mar;41(3):263-8.

Downloads

Published

12/30/2016

Issue

Prev Ped 2015: 1(1)

Section

Case Reports